Article
Research progress on genetic heterogeneity between primary and paired metastatic colorectal cancer.
Yi chuan = Hereditas - 20 Jun 2017
Lu You-Wang, Wang Kun-Hua
Abstract excerpt
Colorectal cancer (CRC) is one of the leading causes of cancer deaths in China. A standard practice in treating metastatic CRC (mCRC) is to predict benefits of the anti-EGFR monoclonal antibody treatment based on the somatic mutation spectrum. Because metastatic samples are difficult to obtain clinically, primary tumors are normally used instead. However, due to the genetic heterogeneity between primary and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
